Study on the effect of pharmaceutical intervention by clinical pharmacists in the managementof clinical irrational drug use
临床药师在临床不合理用药管理中的药学干预效果研究

摘要

目的 谈论临床药师在临床不合理用药管理中的药学干预效果。方法 把我院电脑随机选取于2019年1月份开始，截止到2020年1月份期间的50份病人的用药记录作为对照组，把于2020年1月份开始，截止到2021年3月份期间的70份病人的用药记录作为观察组。前者实行常规形式的药学干预，后者实行优质的药学干预。查看两小组病人的处方使用不合理情况、药学服务质量。结果 实验组病人经有效干预后其处方使用不合理情况（11.43%）得到理想改善且低于对照组（28.00%）；组间数据对比可知，实验组病人经有效干预后其可靠性、反应性、保证性、移情性及有形性得到理想提升且高于对照组，用（P＜0.05）代表组间差异明显，具有研究性。结论 从临床药师的角度增强对不合理用药的管理，利于各科室形成良好的临床用药情况，确保患者用药期间的安全性更高，减少医患纠纷现象的发作，值得增大临床推广范围与力度。

Abstract

Objective To discuss the effect of pharmaceutical intervention by clinical pharmacists in the management of clinical irrational drug use.
Methods The computer in our hospital randomly selected 50 patients' medication records from January 2019 to January 2020 as the control group, and took 70 patients from January 2020 to March 2021. The medication records of the patients were used as the observation group. The former implements conventional forms of pharmaceutical intervention, while the latter implements high-quality pharmaceutical intervention. Check the unreasonable use of prescriptions and the quality of pharmaceutical services in the two groups of patients.
Results After effective intervention, the irrational use of prescriptions in the experimental group (11.43%) was improved ideally and was lower than that in the control group (28.00%). The data comparison between the groups showed that the reliability and response of patients in the experimental group after effective intervention Sexuality, assurance, empathy and tangibility were ideally improved and higher than those in the control group, with (P<0.05) representing significant differences between groups, which is of research interest.
Conclusion   Strengthening the management of irrational drug use from the perspective of clinical pharmacists is conducive to the formation of a good clinical drug use situation in each department, ensuring higher safety for patients during drug use, and reducing the occurrence of doctor-patient disputes. It is worth expanding the scope of clinical promotion and strength.